Multidisciplinary Thoracic Cancers Symposium - 2017
March 16-18, 2017
San Francisco Marriot Marquis
The 2017 Multidisciplinary Thoracic Cancer Symposium is a two-and-a-half day meeting featuring interactive case discussions; educational sessions on new multidisciplinary therapies, new targeted therapies, immunotherapy, treatment and screening guidelines, supportive care; and oral abstract sessions highlighting the most current, evidence-based practices. The goal of this meeting is to provide participants with updates on current early phase clinical and translational initiatives in thoracic malignancies, including targeted therapy, immunotherapy, advanced radiation and surgical methodologies, and pathological advancements in molecular categorization that are relevant to daily clinical practice. Additionally, the attendees will be updated on the appropriate integration of all the advancements in their daily practice, including indication, patient selection, combinations of different therapeutic modalities, prevention and management of common toxicities.
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pulmonologists and pathologists.
Upon completion of this live activity, attendees should be able to do the following:
- Discuss the relevance of the precision medicine initiative for clinical practice in thoracic malignancies.
- Explain the appropriate integration of targeted and immunotherapy in the daily clinical management of thoracic malignancies.
- Explain the application and limitations of advanced radiation and surgical techniques in thoracic malignancies.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
ASTRO designates this live activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 19.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 19.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 19.00 Certificate of AttendanceThis activity was designated for 19.00 AMA PRA Category 1 Credit™.